Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCarthy, J.
Right arrow Articles by Staats, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by McCarthy, J.
Right arrow Articles by Staats, B.

Chest, Vol 89, 608-611, Copyright © 1986 by American College of Chest Physicians

ARTICLES

Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome

JT McCarthy and BA Staats

After treatment with mitomycin C, a patient developed pulmonary hypertension with interstitial infiltrates, microangiopathic hemolytic anemia, systemic hypertension, and renal failure with the nephrotic syndrome. Open lung biopsy documented intracapillary fibrin thrombi in the pulmonary vasculature. Renal biopsy documented glomerular and arteriolar changes that were most consistent with a thrombotic- thrombocytopenic-like process. Treatment with corticosteroids, fresh- frozen plasma, and total plasma exchange was ineffective. The patient died six months after the onset. When mitomycin-C therapy is given, the clinician should be aware of the pulmonary, renal, and microangiopathic changes that can be associated with such therapy.


This article has been cited by other articles:


Home page
 JAMAHome page
R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease
JAMA, April 6, 2005; 293(13): 1653 - 1662.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. Azoulay, S. Eddahibi, E. Marcos, M. Levame, A. Harf, B. Schlemmer, S. Adnot, and C. Delclaux
Granulocyte colony-stimulating factor enhances alpha-naphthylthiourea-induced pulmonary hypertension
J Appl Physiol, May 1, 2003; 94(5): 2027 - 2033.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
J. Vansteenkiste, P. De Leyn, G. Deneffe, J. Menten, T. Lerut, and M. Demedts
Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review
Eur. J. Cardiothorac. Surg., January 1, 1998; 13(1): 1 - 12.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American College of Chest Physicians.